Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
260M
-
Number of holders
-
749
-
Total 13F shares, excl. options
-
187M
-
Shares change
-
+10.4M
-
Total reported value, excl. options
-
$6.53B
-
Value change
-
+$393M
-
Put/Call ratio
-
0.7
-
Number of buys
-
279
-
Number of sells
-
-490
-
Price
-
$34.93
Significant Holders of Organon & Co. - Common Stock (OGN) as of Q1 2022
924 filings reported holding OGN - Organon & Co. - Common Stock as of Q1 2022.
Organon & Co. - Common Stock (OGN) has 749 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 187M shares
of 260M outstanding shares and own 71.9% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (29.2M shares), BlackRock Inc. (16.9M shares), STATE STREET CORP (12M shares), JANUS HENDERSON GROUP PLC (11.4M shares), Bank of New York Mellon Corp (8.43M shares), Mawer Investment Management Ltd. (8.3M shares), LORD, ABBETT & CO. LLC (8.09M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (6.48M shares), GEODE CAPITAL MANAGEMENT, LLC (5.53M shares), and Invesco Ltd. (3.51M shares).
This table shows the top 749 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.